Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Dose-reduced NOACs may be safer than warfarin in some AFib patients

    October 31, 2019

    Are dose-­reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?

  • News

    Dapagliflozin approved for reducing HF hospitalization in diabetes

    October 21, 2019

    It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.

  • 1
    News

    Minimize blood pressure peaks, variability after stroke reperfusion

    October 15, 2019

    ST. LOUIS – Controlling blood pressure variability improves outcomes after stroke.

  • 1
    News

    FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients

    October 15, 2019

    The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.

  • 1
    News

    Automated ventilation outperformed nurses in post-op cardiac care

    October 13, 2019

    MADRID – Automated mechanical ventilation keeps post-op patients in safe breathing zones better than nurses.

  • News

    Short-term statin use linked to risk of skin and soft tissue infections

    October 11, 2019

    Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days.

  • 1
    News

    TAVR, SAVR share same infective endocarditis risk

    October 3, 2019

    PARIS – “Be aware, be careful, and provide appropriate antibiotic prophylaxis, just as surgeons do in SAVR,” said Dr. Laurent Fauchier.

  • 1
    Video

    Novel cardiac troponin protocol rapidly rules out MI

    October 3, 2019

    PARIS – Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission.

  • 1
    News

    FDA adds diabetic kidney disease, heart failure indications to canagliflozin

    September 30, 2019

    This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.

  • 1
    News

    Ticagrelor monotherapy tops DAPT for high-risk PCI patients

    September 29, 2019

    SAN FRANCISCO – TWILIGHT findings support move to shorter DAPT.

Previous1 … 41 42 43 44 45 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences